Cumberland Pharmaceuticals(CPIX) - 2025 Q4 - Annual Results

CUMBERLAND PHARMACEUTICALS REPORTS 31.1% FOURTH QUARTER 2025 REVENUE GROWTH Cumberland to highlight 2025 financial, international, portfolio and clinical progress NASHVILLE, Tenn. (Tuesday, March 3, 2026) – Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $13.7 million during the fourth quarter of 2025, a 31% increase over the prior year period. Net revenues for the full ye ...